Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Pancreatic Neoplasms 6Prostatic Neoplasms 3Multiple Myeloma 3Colorectal Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Rectal Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Melanoma 2Glioblastoma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Solid Tumor 1Sarcoma, Clear Cell 1Refractory or Relapsed Solid Tumors 1Platinum-resistant Epithelial Ovarian Cancer 1Neoplasm Metastasis 1Malignant Solid Tumour 1Lymphangioleiomyomatosis 1Lung Neoplasms 1Liver Neoplasms 1Klatskin Tumor 1Gliosarcoma 1Gastrointestinal Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Arthritis, Rheumatoid 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79Bevacizumab 75pembrolizumab 74Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Hydroxychloroquine × Clear all
NCT02232243 2021-06-28

HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors

University of Kentucky

Phase 1 Completed
10 enrolled 9 charts
Tumor-Agnostic

Neoplasms

NCT01266057 2021-03-04

Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
143 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡